RNA-binding protein NOVA1 promotes acute T-lymphocyte leukemia progression by stabilizing USP44 mRNA
Biochemistry and Cell Biology · 2024
DOI: 10.1139/bcb-2023-0092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemistry and Cell Biology, 2024. Verfasst von Bin Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: The First Department of Pediatric HematologyShengjing Hospital of China Medical University, Shenyang 110004, Liaoning, China. Hauptthemen laut MEDLINE: Neuro-Oncological Ventral Antigen, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Acute T-lymphocyte leukemia (T-ALL) is a malignant tumor disease. RNA-binding protein neotumor ventral antigen-1 (NOVA1) is highly expressed in bone marrow mononuclear cells of T-ALL patients, while the role of NOVA1 in T-ALL progression remains unknown. The gain- and loss-of-function studies for NOVA1 were performed in Jurkat and CCRF-CEM cells. NOVA1 overexpression promoted cell proliferation and cell cycle progression. NOVA1 knockdown increased the apoptosis rate of T-ALL cells. Ubiquitin-specific protease 44 (USP44), a nuclear protein with deubiquitinase catalytic activity, has been reported to play an oncogene role in human T-cell leukemia. USP44 expression was positively associated with NOVA1, and RNA immunoprecipitation assay verified the binding of NOVA1 to the mRNA of USP44. USP44 knockdown partially abolished NOVA1-induced cell proliferation and inhibition of apoptosis. The in vivo xenograft experiment was performed by injection of T-ALL tumor cells into the tail vein of NOD/SCID mice. The knockdown of NOVA1 had lower tumorigenicity. NOVA1 knockdown alleviated pathological changes in lung and spleen tissues, and increased the overall survival period and the weight of T-ALL mice. Thus, NOVA1 acts as an accelerator in T-ALL, and its function might be achieved by binding to and stabilizing USP44 mRNA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Department of Pediatric HematologyShengjing Hospital of China Medical University, Shenyang 110004, Liaoning, China.
- The Second Department of Pediatric HematologyShengjing Hospital of China Medical University, Shenyang 110004, Liaoning, China.
ORCID-Profile: Zuofei Chi
Zitieren
APA
Zhang, B., Sun, R., Gu, M., Jiang, Z., Wang, Y., Zhang, L., Liu, X., & Chi, Z. (2024). RNA-binding protein NOVA1 promotes acute T-lymphocyte leukemia progression by stabilizing USP44 mRNA. Biochemistry and Cell Biology. https://doi.org/10.1139/bcb-2023-0092
Vancouver
Zhang B, Sun R, Gu M, Jiang Z, Wang Y, Zhang L, et al. RNA-binding protein NOVA1 promotes acute T-lymphocyte leukemia progression by stabilizing USP44 mRNA. Biochemistry and Cell Biology. 2024. doi:10.1139/bcb-2023-0092
BibTeX
@article{Zhang2024,
author = {Zhang, Bin and Sun, Ruowen and Gu, Min and Jiang, Zehui and Wang, Ye and Zhang, Linlin and Liu, Xiaoyang and Chi, Zuofei},
title = {RNA-binding protein NOVA1 promotes acute T-lymphocyte leukemia progression by stabilizing USP44 mRNA},
journal = {Biochemistry and Cell Biology},
year = {2024},
doi = {10.1139/bcb-2023-0092}
}
EUVIMED